Outpatiented · Case Knowledge
A cough that lingers for 2 to 8 weeks after a viral illness is extremely common and almost never means the infection is ongoing. What post-viral cough actually is, why antibiotics and steroids are not the answer, and what you actually need to know before visiting a newborn.
What Post-Viral Cough Actually Is
When a respiratory virus infects the upper and lower airways, it damages the epithelial lining and triggers an inflammatory response. The virus itself is cleared by the immune system typically within 7 to 10 days for rhinovirus and influenza. But the inflammatory changes in the airway lining do not resolve immediately. The result is a period of airway hypersensitivity. The airways are irritated, swollen, and overreactive to stimuli that would not normally trigger a cough response.
This is called post-infectious airway hyperreactivity, or post-viral cough. It is the same underlying mechanism as reactive airway disease or transient cough-variant asthma triggered by viral illness. Cold air, talking, laughing, dry environments, or postnasal drip all become cough triggers that would not bother the same person when healthy.
The cough is real and can be persistent and disruptive. It is not psychosomatic and it is not a sign that the person failed to fight off the infection. It is the normal aftermath of airway inflammation that takes longer to resolve than the infection itself.
Post-viral cough typically lasts 2 to 8 weeks after the acute illness resolves. Most cases improve significantly by 3 to 4 weeks. A cough persisting beyond 8 weeks warrants further evaluation to rule out other causes including post-nasal drip syndrome, GERD, asthma, or less commonly pertussis or other infection.
Cold air, dry air, talking for extended periods, laughing, exercise, postnasal drip running down the back of the throat, and airborne irritants are the typical triggers during the post-viral phase. The cough is often dry and non-productive. Some people describe a tickle or itch at the back of the throat. These features distinguish it from an active lower respiratory infection.
Post-viral inflammation frequently involves the nasal passages and sinuses, producing ongoing postnasal drip, mucus running down the back of the throat. This drip itself triggers cough. When the drip component is present, treating it directly (nasal saline rinse, intranasal steroid, antihistamine) is more effective than cough suppressants alone.
Post-viral cough is not bacterial bronchitis, pneumonia, or a secondary bacterial infection in the absence of fever, purulent sputum, and signs of lower respiratory involvement. Prescribing antibiotics for a 2-week dry cough after a viral URI in an otherwise healthy person without fever is not supported by evidence and contributes to antibiotic resistance.
The cough is not the infection.
The infection is over.
The airways are still catching up.
The Contagious Question
This is the question people most want a definitive answer to, and the honest answer is: it depends on the virus, and there is no single test that clears you. Here is what is actually known.
Rhinovirus shedding is highest in the first 2 to 3 days of illness when symptoms are most prominent. Most viral shedding has ended by 7 to 10 days after symptom onset in immunocompetent adults. A persistent cough at 2 weeks after rhinovirus illness is almost always post-viral airway irritation, not active viral shedding. Contagious risk at 2 weeks is very low for rhinovirus.
Influenza shedding typically begins 1 day before symptoms appear and lasts 5 to 7 days from symptom onset in adults. Children and immunocompromised individuals may shed longer. At 2 weeks after flu symptom onset, flu contagiousness is extremely unlikely. The lingering cough is post-viral, not active flu.
RSV (respiratory syncytial virus) shedding in adults typically lasts 3 to 8 days. However, RSV is the most important consideration when visiting a newborn because it causes severe lower respiratory illness in infants under 3 months. In immunocompromised individuals, RSV shedding can last weeks. If RSV has not been ruled out by testing and you are visiting a newborn. This is the specific risk that matters most. A residual cough is not a reliable marker of whether RSV is still being shed.
At 2 weeks post-illness with no fever and a dry cough as the only remaining symptom, contagious risk for standard respiratory viruses is low. But "low" and "zero" are different, and for a newborn, whose immune system is immature and for whom RSV in particular can cause serious illness, the risk calculus is different than for visiting healthy adults. The cough itself is not a reliable indicator of whether viral shedding is still occurring. It is an airway response, not a transmission event.
Option 1: Test first. A NAAT (nucleic acid amplification test) for flu, RSV, and COVID from a nasal swab can confirm whether you are actively shedding these specific viruses. A negative result on all three provides meaningful reassurance for a newborn visit. This is available at many urgent care facilities and through some at-home testing options. It is the most defensible path if the visit cannot be deferred.
Option 2: Defer the visit. Wait until the cough is fully resolved and you have had a symptom-free interval. For a newborn under 2 months especially, deferring by even a week or two is a reasonable, conservative choice. The visit can happen. It just happens when the biological picture is cleaner.
What is not an option: a guarantee that a residual cough means you are not contagious. That guarantee does not exist without testing. Anyone who tells you definitively you are clear based on duration alone is giving you more certainty than the biology supports.
Why Antibiotics and Steroids Are Not the Answer
Two prescriptions people commonly request for a lingering post-viral cough: antibiotics (because the cough has lasted a long time, so it must be bacterial now) and steroids (because steroids help coughs, or because someone else got them). Both requests are understandable. Neither is appropriate in the standard post-viral cough presentation.
Antibiotics target bacteria. Post-viral cough is caused by airway inflammation following a viral infection, the virus has already been cleared by the immune system. There is no bacterial target for the antibiotic to act on in a post-viral cough without fever, purulent (green/yellow) sputum production, and signs of lower respiratory involvement. Prescribing antibiotics in this situation does not shorten the cough duration, does not reduce symptom severity, and does contribute to antibiotic resistance and disruption of gut microbiome. Duration alone, even weeks, does not convert a post-viral cough into a bacterial illness.
Oral corticosteroids are powerful anti-inflammatory agents with significant side effects including blood sugar elevation, immune suppression, mood changes, and bone density effects with repeated use. They are indicated for post-viral cough when the inflammation has progressed to reactive airway disease with audible wheezing, significant dyspnea (shortness of breath), or documented bronchospasm on exam. For a dry cough without wheezing, without breathing difficulty, and without hypoxia, oral steroids are not indicated, the risk-benefit calculation does not support them. Someone else receiving steroids for their cough does not mean those steroids were appropriately prescribed, and it does not mean you have the same presentation.
Questions People Actually Ask
I still have a cough 2 weeks after my cold. Is it still contagious?
Almost certainly not for the original virus. Most common cold viruses (rhinovirus) and influenza are no longer being shed at 2 weeks after symptom onset in otherwise healthy adults. The cough at this point is post-viral airway irritation, not active infection. You are not coughing up live virus in most cases.
The exception worth knowing about: if you were never tested and RSV was the cause, or if you are immunocompromised, shedding timelines can be longer. For visiting healthy adults, the risk at 2 weeks with no fever is low enough that most people would not restrict activity. For visiting a vulnerable person, a newborn, an elderly person, or someone immunocompromised, the honest answer is to test or defer rather than assume clearance.
My doctor said my cough is viral but I have had it for 3 weeks. Shouldn't I take antibiotics just in case?
No, duration does not convert a post-viral cough into a bacterial infection. This is one of the most common misconceptions in respiratory illness management. The belief is: if a cough lasts long enough, it must have become bacterial. This is not how it works. Post-viral airway hyperreactivity can last 2 to 8 weeks. The absence of fever, the dry nature of the cough, and the absence of purulent sputum all indicate that no bacterial superinfection has occurred.
Antibiotics taken for a viral cough do nothing to shorten the cough, provide no benefit, and carry real downsides: disruption of gut microbiome, risk of Clostridioides difficile colitis, and contribution to antibiotic resistance at the population level. The clinical test is not duration. It is the presence of signs of bacterial infection: fever, productive cough with purulent sputum, worsening rather than stable symptoms, and exam findings consistent with bacterial bronchitis or pneumonia.
What actually helps a post-viral cough?
Address the two main drivers: airway irritation and postnasal drip.
For airway irritation: humidified air (a humidifier in the bedroom) reduces the dry airway trigger. Avoiding cold dry air when possible. Honey has evidence for reducing cough severity, 1 to 2 teaspoons before bed is a legitimate option. Guaifenesin (Mucinex) as an expectorant loosens any mucus and may reduce cough frequency. Hard candy or lozenges can soothe the airway between coughing episodes.
For postnasal drip: nasal saline rinse or spray clears the nasal passages and reduces drip volume. An intranasal corticosteroid spray (Flonase, Nasacort, both over the counter) reduces nasal inflammation and drip when used consistently for 1 to 2 weeks. An oral antihistamine (particularly a first-generation one like diphenhydramine at night) can reduce mucus production and help with sleep disruption from overnight coughing.
What helps least: cough suppressants like dextromethorphan have modest evidence in adults. They can reduce cough frequency but do not address the underlying airway irritation. They are reasonable for nighttime use to improve sleep.
Is it safe to visit a newborn if I still have a cough?
It depends on the newborn's age, what virus you had, and whether you have tested. For a newborn under 2 months, the risk calculation is more conservative than for an older infant or child. Newborns have immature immune systems and no vaccination protection yet. RSV in particular can cause bronchiolitis in young infants that requires hospitalization.
The cleanest path: get a NAAT respiratory panel (flu, RSV, COVID minimum) from an urgent care or your provider. A negative panel on all three is meaningful reassurance. If you cannot or choose not to test, deferring the visit until the cough has fully resolved and you have had several days symptom-free is the most conservative and defensible choice.
If you do visit: wear a mask, wash hands thoroughly, avoid kissing the baby's face or hands, and limit time in close contact with the infant's breathing space. These precautions reduce but do not eliminate transmission risk. No one can guarantee you are not contagious without testing. That is the honest answer, even if it is not the one people want to hear.
How long before I stop coughing after a cold?
Most post-viral coughs resolve within 3 to 4 weeks, though the full range is 2 to 8 weeks. The trajectory should be gradual improvement, fewer episodes per day, less intensity, less disruption to sleep. A cough that is progressively worsening rather than gradually improving is not following the post-viral pattern and should be evaluated.
Factors that can extend duration: smoking or nicotine use (airway irritation on top of airway irritation), significant postnasal drip component that is not being treated, dry indoor air, pre-existing reactive airway disease or asthma, and significant exposures to airborne irritants. Addressing these factors speeds resolution. The underlying biology resolves as the airway epithelium repairs itself. This takes time and cannot be pharmacologically accelerated in most cases.
The MAP Tool follows the thread through your symptom pattern, your history, and your context until something real emerges.
Start Your Map